Reuters logo
2 months ago
BRIEF-Sciclone Pharmaceuticals - Sciclone Pharmaceuticals merger deal with consortium led by Gl Capital's termination fee set at $15.8 mln ‍​
June 8, 2017 / 10:46 AM / 2 months ago

BRIEF-Sciclone Pharmaceuticals - Sciclone Pharmaceuticals merger deal with consortium led by Gl Capital's termination fee set at $15.8 mln ‍​

June 8 (Reuters) - Sciclone Pharmaceuticals Inc:

* Sciclone Pharmaceuticals - sciclone pharmaceuticals merger deal with consortium led by gl capital's termination fee set at $15.8 million - sec filing‍​ ‍​

* Sciclone pharmaceuticals inc - merger deal's reverse termination fee set at about $31.6 million ‍​ Source text (bit.ly/2rPG9qY) Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below